The regulation of sequential processing of HIV-1 gag by the viral protease

被引:0
|
作者
Pettit, SC
Sheng, NJ
Tritch, R
Erickson-Viitanen, S
Swanstrom, R [1 ]
机构
[1] Dupont Merck Pharmaceut Co, Lineberger Comprehens Canc Ctr, Wilmington, DE 19880 USA
[2] Dupont Merck Pharmaceut Co, Dept Mol Biol, Wilmington, DE 19880 USA
[3] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:15 / 25
页数:11
相关论文
共 50 条
  • [1] CLEAVAGE OF HIV-1 GAG POLYPROTEIN SYNTHESIZED INVITRO - SEQUENTIAL CLEAVAGE BY THE VIRAL PROTEASE
    ERICKSONVIITANEN, S
    MANFREDI, J
    VIITANEN, P
    TRIBE, DE
    TRITCH, R
    HUTCHISON, CA
    LOEB, DD
    SWANSTROM, R
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1989, 5 (06) : 577 - 591
  • [2] Accumulation of HIV-1 Gag and Gag-Pol processing intermediates in the presence of non-peptidomimetic HIV-1 protease inhibitors
    Speck, RR
    Yu, XF
    Flexner, C
    ANTIVIRAL RESEARCH, 2000, 46 (01) : A71 - A71
  • [3] HIV-1 PROTEASE SPECIFICITY OF PEPTIDE CLEAVAGE IS SUFFICIENT FOR PROCESSING OF GAG AND POL POLYPROTEINS
    DARKE, PL
    NUTT, RF
    BRADY, SF
    GARSKY, VM
    CICCARONE, TM
    LEU, CT
    LUMMA, PK
    FREIDINGER, RM
    VEBER, DF
    SIGAL, IS
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 156 (01) : 297 - 303
  • [4] SYNTHETIC HIV-2 PROTEASE CLEAVES THE GAG PRECURSOR OF HIV-1 WITH THE SAME SPECIFICITY AS HIV-1 PROTEASE
    WU, JC
    CARR, SF
    JARNAGIN, K
    KIRSHER, S
    BARNETT, J
    CHOW, J
    CHAN, HW
    CHEN, MS
    MEDZIHRADSZKY, D
    YAMASHIRO, D
    SANTI, DV
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1990, 277 (02) : 306 - 311
  • [5] Context Surrounding Processing Sites Is Crucial in Determining Cleavage Rate of a Subset of Processing Sites in HIV-1 Gag and Gag-Pro-Pol Polyprotein Precursors by Viral Protease
    Lee, Sook-Kyung
    Potempa, Marc
    Kolli, Madhavi
    Ozen, Aysegul
    Schiffer, Celia A.
    Swanstrom, Ronald
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (16) : 13279 - 13290
  • [6] Role of HIV-1 Gag domains in viral assembly
    Scarlata, S
    Carter, C
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2003, 1614 (01): : 62 - 72
  • [7] Persistence of processed HIV-1 Gag and Gag-Pol proteins following treatment with HIV-1 protease inhibitors.
    Speck, RR
    Yu, XF
    Flexner, C
    FASEB JOURNAL, 2000, 14 (04): : A185 - A185
  • [8] Novel determinants in HIV-1 gag regulate protease activity and viral fitness in a drug resistant variant
    Koch, S
    O'Brien, P
    Rose, S
    Pomeroy, S
    Dunn, B
    Sleasman, J
    Goodenow, M
    ANTIVIRAL THERAPY, 2005, 10 (04) : S179 - S179
  • [9] Mutations in HIV-1 gag and pol Compensate for the Loss of Viral Fitness Caused by a Highly Mutated Protease
    Kozisek, Milan
    Henke, Sandra
    Saskova, Klara Grantz
    Jacobs, Graeme Brendon
    Schuch, Anita
    Buchholz, Bernd
    Mueller, Viktor
    Kraeusslich, Hans-Georg
    Rezacova, Pavlina
    Konvalinka, Jan
    Bodem, Jochen
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (08) : 4320 - 4330
  • [10] Novel determinants in HIV-1 gag regulate protease activity and viral fitness in a drug resistant variant
    Koch, S
    O'Brien, P
    Rose, S
    Pomeroy, S
    Dunn, B
    Sleasman, J
    Goodenow, M
    ANTIVIRAL THERAPY, 2005, 10 : S179 - S179